ESC Professional Premium Access

Clinical risk prediction for left atrial appendage thrombus among patients with atrial fibrillation

Congress Presentation

About the speaker

Doctor Peter Kistler

Nil, Melbourne (Australia)
3 presentations
0 follower

4 more presentations in this session

Risk of stroke and transient ischemic attack after elective cardioversion of atrial fibrillation: A nationwide study in Finland

Speaker: Mrs S. Itainen-Stromberg (Helsinki, FI)


Left atrial appendage occlusion versus standard of care in patients with atrial fibrillation and a prior thrombo-embolic event despite oral anticoagulant therapy: a propensity score matched comparison

Speaker: Professor L. Boersma (Nieuwegein, NL)


Decreased device related thrombus and enhanced neo-endocardial tissue maturation with a new generation left atrial appendage closure (LAAC) device. An anticoagulation and antiplatelet free canin study

Speaker: Professor W. Saliba (Cleveland, US)


Impact of ABC pathway adherence in high-risk patients with atrial fibrillation: an analysis from the ESC-EHRA EORP-AF long-term general registry

Speaker: Doctor W. Ding (Liverpool, GB)


Access the full session

Stroke prevention by anticoagulation and appendage occlusion in atrial fibrillation

Speakers: Doctor P. Kistler, Mrs S. Itainen-Stromberg, Professor L. Boersma, Professor W. Saliba, Doctor W. Ding

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb